Vinayaga Moorthi

Dr. Vinayaga Moorthi


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2013 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
ABA. Najitha Banu
A. Najitha Banu
CBC. Balasubramanian
C. Balasubramanian
VMVinayaga Moorthi
Vinayaga Moorthi

21 September 2014 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
VMVinayaga Moorthi
Vinayaga Moorthi
CBC. Balasubramanian
C. Balasubramanian
SMS. Mohan
S. Mohan

6 November 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
VMVinayaga Moorthi
Vinayaga Moorthi
CBC. Balasubramanian
C. Balasubramanian
SSS. Selvarani
S. Selvarani
ARA. Radha
A. Radha
In the present investigation, impact of sub lethal concentrations of entomopathogenic fungi, namely Isaria fumosorosea, Beauveria bassiana and Paecilomyces variotii, secondary metabolite on feeding, growth, fecundity and hatchability of Spodoptera litura was performed. The S. litura treated with I. fumosorosea and B. bassiana metabolites exhibited renounced food consumption. The growth rate of treated S. litura with metabolite of I. fumosorosea had drastic reduction. In the case of approximate digestibility (AD), maximum impact was established by the I. fumosorosea isolate, which significantly reduced the approximate digestibility of the IV and V instar larvae. The III instar larvae of S. litura treated with I. fumosorosea metabolite showed significantly lower efficiency of conversion of digested food (ECD) and efficiency of conversion of ingested food (ECI) values than IV and V instars. However the performance of metabolites on fecundity and hatchability of S. litura was immense. Therefore, metabolites of I. fumosorosea could be reliable biocontrol agent, which has been highly recommended for S. litura management in commercial crops.

6 January 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PBPreethi Basavaraju
Preethi Basavaraju
RBRubadevi Balasubramani
Rubadevi Balasubramani
DKDivya Sri Kathiresan
Divya Sri Kathiresan
IDIlakkiyapavai Devaraj
Ilakkiyapavai Devaraj
KBKavipriya Babu
Kavipriya Babu
VMVinayaga Moorthi
Vinayaga Moorthi
Apolipoproteins (APO proteins) are the lipoprotein family proteins that play key roles in transporting lipoproteins all over the body. There are nearly more than twenty members reported in the APO protein family, among which the A, B, C, E, and L play major roles in contributing genetic risks to several disorders. Among these genetic risks, the single nucleotide polymorphisms (SNPs), involving the variation of single nucleotide base pairs, and their contributing polymorphisms play crucial roles in the apolipoprotein family and its concordant disease heterogeneity that have predominantly recurred through the years. In this review, we have contributed a handful of information on such genetic polymorphisms that include APOE, ApoA1/B ratio, and A1/C3/A4/A5 gene cluster-based population genetic studies carried throughout the world, to elaborately discuss the effects of various genetic polymorphisms in imparting various medical conditions, such as obesity, cardiovascular, stroke, Alzheimer's disease, diabetes, vascular complications, and other associated risks.

18 October 2016 in International Journal of Current Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
CSChittakath Shaima
Chittakath Shaima
VMVinayaga Moorthi
Vinayaga Moorthi
SKShaheen Naser Kutty
Shaheen Naser Kutty
Objective: 5’ Fluorouracil (5’FU) loaded chitosan nanoparticle (5FCN) was synthesized and tested for its anticancer activity against Hep G2, the liver cancer cell line.Methods: The morphological characteristic of the 5FCN was visualized in Scanning Electron Microscope (SEM).Results: The 5FCN revealed an IC50 value of 49.50 µl/ml. The study revealed that the 5FCN exhibited excellent anticancer activity against Hep G2 cell line which can be further studied for its application in cancer treatment.Conclusion: Further studies would be focused onto report the drug release efficiency under different physiological conditions and evaluate them in animal model.

17 October 2024 in Acta Diabetologica
Verified
Journal Article
Open access
PDF file
PBPreethi Basavaraju
Preethi Basavaraju
VMVinayaga Moorthi
Vinayaga Moorthi
AMArun Meyyazhagan
Arun Meyyazhagan
IDIlakkiyapavai Devaraj
Ilakkiyapavai Devaraj
KBKavipriya Babu
Kavipriya Babu
AOAntonio Orlacchio
Antonio Orlacchio
Background: Diabetic nephropathy (DN) is a grave complication and the most common renal dysfunction of diabetes mellitus. Genetic factors, including Apolipoprotein E (APOE) isoforms, have been implicated in the pathogenesis of DN. Methods: A total of 577 type 2 Diabetes mellitus subjects were categorized into diabetes non-nephropathic (Controls: n = 321), diabetes nephropathic (DN: n = 256) groups. Demographic, clinical, and biochemical parameters including age, BMI, lipid profiles (TC, LDL-C, HDL-C, TG), glucose metabolism (plasma glucose, HbA1c, serum insulin), renal function (UACR, PCR), and blood pressure (SBP, DBP) were assessed. APOE variant frequencies were determined using restriction fragment length polymorphism (RFLP) analysis, validated against Hardy-Weinberg equilibrium (HWE), and statistically correlated with each clinical and biochemical parameter. Results: The DN group had an increased prevalence of hypertension, fatty liver, and dyslipidemia compared to the Control group. Biochemical analyses revealed elevated levels of TC (213.41 mg/dL vs. 189.32 mg/dL), LDL-C (134.46 mg/dL vs. 107.56 mg/dL), and reduced HDL-C (58.13 mg/dL vs. 65.32 mg/dL) in DN cases compared to Controls (all p < 0.0001). The APOE variants distribution showed a significant increase in E2 allele frequency (69.1% vs. 15.3%) and corresponding homozygous genotype (E2/2: 42.2% vs. 5.6%) in DN cohorts. Conclusion: The study found a higher frequency of E2 allele in the DN group compared to Controls, though no statistically significant risk of DN was linked to this allele. The results suggest a potential association for APOE polymorphisms, requiring broader studies to clarify the role of APOE polymorphisms in DN susceptibility.